- Synercon Technologies
- About
- Tailwind
- WeGoLook
- Home
- Contact
- News
- Library
- About Us
- Portfolio
- Investor’s Only
- Portfolios
- Funds
- My Account
- Disclaimer & Disclosure
- Investments
- Oklahoma Angel Fund II Reports
- SSA quarterly reports test
- Directory Dashboard
- Add Listing
- Test Group 2
- 4DSales
- Alkami
- Biolytx Pharmaceuticals
- BP Endo
- Clear River Environ
- CreditPoint Software, Inc.
- Datebox
- Dermamedics
- Digital Six Technologies
- Exaptive
- Expert TA
- iRecommend
- Kirrhos
- Lifetone
- Linear Health Sciences
- MaxQ
- Moleculera Labs
- Monscierge
- Otologics Pharmaceuticals
- PolySkope
- Progentec
- Raw Space for Rent
- Roll to Roll Technologies
- Send a Ride
- Simergent
- Video
- Spiers New Technology
- Tetherex Pharmaceuticals
- THG Energy Solutions
- i2E Directory
- Valve Systems International
- Well Checked Systems
- Whiteboard CRM
- Docvia
- Driven Analytics
- Exerbotics
- OMRF Glioblastoma Project
- Selexys Pharmaceuticals
- This event has passed.
Business Development Strategies; The Secret Sauce of Deal Making
October 6, 2011 @ 8:30 am - 1:00 pm
Business Development Strategies; The Secret Sauce of Deal Making
An Entrepreneur-in-Residence workshop presented by i2E, Inc.
Registration: This is a limited attendance, registration required educational event open to entrepreneurs and investors. Registration deadline is Sept 28, 2011.
To register for Business Development Strategies; The Secret Sauce of Deal Making, please contact Sarah Seagraves at sseagraves@i2E.org or (405) 813-2403.
About the Event: On October 6, i2E will address the issue of Business Development Strategies; The Secret Sause of Deal Making in the fourth event in a series of entrepreneurial workshops.
About the Presenter: Business Development Strategies; The Secret Sauce of Deal Making will be presented by Entrepreneur-in-Residence Jack Anthony.
Jack has over 35 years of Medical Device and Biotechnology leadership experience including: Baxter Healthcare, Sales, Marketing and General Management; Applied Immune Sciences, VP of Marketing and Business Development; Inhale Therapeutics, Vice President of Marketing and Business Development; FibroGen, Vice President of Business Development; Tularik, Senior Vice President of Business Development; Saegis Pharmaceuticals, Vice President of Business Development; Pharmix Corporation, President and CEO.
